General Atlantic Prices Secondary Offering of 13.17 Million Shares Above Market Price
ALHC sits 61% above its 52-week low of $11.625 on elevated volume (2.0× avg).
Summary
General Atlantic has priced a secondary offering of 13.17 million shares of Alignment Healthcare common stock at $19.46 per share, totaling $256.24 million, with the company receiving no proceeds.
Key Events · Ownership and Investor Activity · ALHC
-
Secondary Offering Priced
An affiliate of General Atlantic, L.P. priced a secondary offering of 13,167,733 shares of common stock.
-
Significant Transaction Value
The offering is valued at approximately $256.24 million, representing a substantial portion of the company's market capitalization.
-
Premium Pricing
Shares were priced at $19.46 each, which is above the last reported sale price of $19.22 on February 27, 2026, and above today's market price of $18.77, indicating strong demand.
-
No Proceeds to Company
Alignment Healthcare, Inc. will not receive any proceeds from the sale of shares by the selling stockholder.
Analysis · ALHC · Finance
This 424B7 filing finalizes the terms and pricing of a significant secondary offering by General Atlantic, an affiliate of General Atlantic, L.P., which was previously announced in news on March 2nd and 3rd. The offering involves 13,167,733 shares of common stock, valued at approximately $256.24 million. While the company will not receive any proceeds from this sale, the offering was priced at $19.46 per share, which is above the last reported sale price of $19.22 on February 27, 2026, and also above today's market price of $18.77. This premium pricing suggests strong institutional demand and confidence in the company's valuation, despite a major investor liquidating a substantial portion of its stake. The offering follows the S-3ASR shelf registration filed on March 2, 2026, and comes shortly after the company reported strong Q4 and full-year 2025 results that beat guidance.
At the time of this filing, ALHC was trading at $18.77 on NASDAQ in the Finance sector, with a market capitalization of approximately $3.8B. The 52-week trading range was $11.63 to $23.87. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.